P
Peter Pickkers
Researcher at Radboud University Nijmegen
Publications - 551
Citations - 24686
Peter Pickkers is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Sepsis & Intensive care. The author has an hindex of 70, co-authored 501 publications receiving 17971 citations. Previous affiliations of Peter Pickkers include Radboud University Nijmegen Medical Centre & Waikato Hospital.
Papers
More filters
Journal ArticleDOI
Urine Biomarkers for Gentamicin-Induced Acute Kidney Injury in the Nicu
Diana Jansen,Suzanne Heemskerk,Linda Koster-Kamphuis,TP Bouw,A.F.J. van Heijst,Peter Pickkers +5 more
TL;DR: To determine whether urine biomarkers are useful for early detection of gentamicin-induced AKI in neonates in the NICU, fourty-four neonates with a bladder catheter without pre-existent kidney disease were divided into a GM and a reference group.
Journal Article
Calcitonin gene-related peptide induced vasodilation depends on the release of nitric oxide
Journal ArticleDOI
International validation of the delirium prediction model for ICU patients (PREDELIRIC): a multicenter observational study
M van den Boogaard,Lisette Schoonhoven,Emilio Maseda,C. Plowright,Christina Jones,Alawi Luetz,Peter V. Sackey,Philippe G. Jorens,Leanne M. Aitken,F van Haren,J.G. van der Hoeven,Peter Pickkers +11 more
TL;DR: The aim of this study was to internationally validate the existing Prediction of Delirium ICU (PREDELIRIC) model to predict delirium in ICU patients.
Journal ArticleDOI
Evidence‐based rationale for low dose nivolumab in critically ill patients with sepsis‐induced immunosuppression
L.S. Otten,Hans J. P. M. Koenen,Ruben L. Smeets,Berber Piet,Peter Pickkers,Matthijs Kox,Rob ter Heine +6 more
TL;DR: In this paper , the PD-1 inhibitor nivolumab was evaluated in phase I/II studies in patients with sepsis, demonstrating tolerability and signs of clinical efficacy.